Covered recipient · General Payments record
TINA WATKINS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$4,046.69
- Reported across 195 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $706.60 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $392.82 | 20 |
| Amgen Inc. | $93.61 | 4 |
| GENZYME CORPORATION | $75.85 | 5 |
| Janssen Biotech, Inc. | $33.80 | 2 |
| PFIZER INC. | $28.95 | 2 |
| E.R. Squibb & Sons, L.L.C. | $28.37 | 1 |
| Biofrontera Inc. | $20.69 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $16.90 | 1 |
| REVANCE THERAPEUTICS, INC. | $15.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.69 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383639 | CMS |
| ABBVIE INC. | $21.68 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383641 | CMS |
| ABBVIE INC. | $5.05 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383643 | CMS |
| ABBVIE INC. | $5.43 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383645 | CMS |
| ABBVIE INC. | $28.44 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383647 | CMS |
| ABBVIE INC. | $9.36 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383649 | CMS |
| ABBVIE INC. | $20.16 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383651 | CMS |
| ABBVIE INC. | $118.63 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383653 | CMS |
| ABBVIE INC. | $21.97 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383655 | CMS |
| ABBVIE INC. | $0.17 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383657 | CMS |
| ABBVIE INC. | $45.08 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383659 | CMS |
| ABBVIE INC. | $14.31 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383661 | CMS |
| ABBVIE INC. | $5.97 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383663 | CMS |
| ABBVIE INC. | $0.42 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383665 | CMS |
| ABBVIE INC. | $20.96 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383667 | CMS |
| ABBVIE INC. | $15.24 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383669 | CMS |
| ABBVIE INC. | $9.32 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383671 | CMS |
| ABBVIE INC. | $16.44 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383673 | CMS |
| ABBVIE INC. | $3.38 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383675 | CMS |
| ABBVIE INC. | $4.12 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108383677 | CMS |
| Amgen Inc. | $21.00 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117714258 | CMS |
| Amgen Inc. | $27.89 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117714260 | CMS |
| Amgen Inc. | $24.25 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117714262 | CMS |
| Amgen Inc. | $20.47 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117714264 | CMS |
| Biofrontera Inc. | $20.69 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1102949671 | CMS |
| E.R. Squibb & Sons, L.L.C. | $28.37 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101768249 | CMS |
| GENZYME CORPORATION | $17.25 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139897524 | CMS |
| GENZYME CORPORATION | $14.75 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139897546 | CMS |
| GENZYME CORPORATION | $14.59 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139897568 | CMS |
| GENZYME CORPORATION | $15.52 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139897560 | CMS |
| GENZYME CORPORATION | $13.74 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139897610 | CMS |
| Janssen Biotech, Inc. | $17.62 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078807429 | CMS |
| Janssen Biotech, Inc. | $16.18 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078807304 | CMS |
| PFIZER INC. | $15.88 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131736836 | CMS |
| PFIZER INC. | $13.07 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131926068 | CMS |
| REVANCE THERAPEUTICS, INC. | $15.61 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147953372 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $16.90 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152284687 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.